Document is current
Any future updates will be listed below
-
Authors
Michels, Monique https://orcid.org/0000-0001-8440-1976
Córneo, Emily
Cucker, Luana
Simon, Carla Sasso
de Jesus, Gabriel Fernandes Alves
Michels, Carolina
Madeira, Kristian
Voytena, Ana Paula
Rossetto, Marina
Ramlov, Fernanda
de Castro Damásio, Danusa
Dal-Pizzol, Felipe
-
Funding
Funding for this research was provided by:
GABBIA Biotech
- License Information
-
More Information
Article History
Accepted: 24 December 2021
First Online: 15 January 2022
Declarations
:
: The Ethics Committees of Hospital São José in Criciúma approved the study (Number: 4.449.750/2020 and CAAE number: 40641120.9.0000.5364) and all patients or proxies gave written informed consent, without any refusal. The study was registered in clinical trial = NCT04742322.
: All patients or proxies gave written informed consent, without any refusal.
: All authors approved final version submitted.
: Gabbia Biotechnology are developing <i>B. lactis</i> strain for the commercial purposes. Gabriel Jesus, Marina Rosseto, Ana Paula Voytena, and Fernanda Ramlov are members of Gabbia Biotechnology. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
